Pancreatic Cancer Research

ResearcherUniversity of Florida HealthNo recent work listed

K.E. Behrns

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6131-3305; OpenAlex author ID A5056627737. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2015: 3 papers · 2016: 2 papers · 2017: 4 papers · 2018: none · 2019: none · 2020: 1 paper

Papers 10

  1. Neoadjuvant therapy versus upfront resection for clinically "resectable" pancreatic cancer: The debate continues. First author DOI 10.1016/j.surg.2020.09.031↗
  2. A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2016.09.038↗
  3. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Huma… Co-author DOI 10.1097/mpa.0000000000000843↗
  4. Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment. Co-author DOI 10.1158/0008-5472.can-16-1765↗
  5. Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia. Co-author DOI 10.18632/oncotarget.13593↗
  6. Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture. Co-author DOI 10.1016/j.ajpath.2016.02.009↗
  7. Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1158/1078-0432.ccr-15-1256↗
  8. Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in hum… Co-author DOI 10.1007/s00262-015-1760-y↗
  9. Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements. Co-author DOI 10.1016/j.ajpath.2015.01.016↗
  10. The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival. Co-author DOI 10.1186/s12885-015-1820-x↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel Delitto · 9 shared papers, 2015–2017 · strength 0.49
  2. Steven J. Hughes · 9 shared papers, 2015–2017 · strength 0.49
  3. Jose Gilberto Trevino · 9 shared papers, 2015–2017 · strength 0.49
  4. Thomas J. George · 8 shared papers, 2015–2017 · strength 0.44
  5. Ryan Michael Thomas · 7 shared papers, 2015–2017 · strength 0.36
  6. Shannon Margaret Wallet · 7 shared papers, 2015–2017 · strength 0.35
  7. Chen Liu · 6 shared papers, 2015–2017 · strength 0.29
  8. Michael Gregory Sarr · 1 shared paper, 2020 · strength 0.24
  9. Sarah M. Judge · 3 shared papers, 2017 · strength 0.20
  10. Andrew R. Judge · 3 shared papers, 2017 · strength 0.20
  11. Kien Pham · 4 shared papers, 2015–2017 · strength 0.20
  12. Michael H. Gerber · 3 shared papers, 2017 · strength 0.19
  13. Song Han · 3 shared papers, 2015–2017 · strength 0.15
  14. Kristina L. Go · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.